FDA Import Refusal 112-8043509-9/1/2 — Glaxo Smith Kline Phils Inc
The FDA refused shipment 112-8043509-9/1/2 from Glaxo Smith Kline Phils Inc (Philippines) on Dec 12, 2005. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 118 This firm has 1 other import refusal on record.
Refusal details
- Date
- Dec 12, 2005
- Country
- Philippines
- Product Category
- Drugs and Biologics
- Product Code
- 61JCY08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 118